Increased plasma fibrinogen, decreased erythrocyte distensibility, increased plasma and blood viscosity, increased platelet aggregability, increased plasminigen activator inhibitor levels, vasoconstriction of the coronary bed, reduced fibrillation treshold, increased triglycerides, reduced HDL cholesterol, and increased production of superoxide by phagocytes.
povečane vrednosti plazemskega fibrinogena, zmanjšana fleksibilnost eritrocitov, povečana viskoznost plazme in krvi, povečana agregabilnost trombocitov, povišana raven inhibitorja aktivatorja plazminogena, vazokonstrikcija koronarnega povirja, znižan prag za fibrilacijo, zvišana raven trigliceridov, znižana raven HDL holesterola in povečano nastajanje peroksida v fagocitih.